A. Sartor

Case report: Robotic lymph node resection off the aortic bifurcation for presumed recurrence management of advanced ovarian cancer.

G. Menderes, A. Wilcox, A. Sartor, 2023, International journal of surgery case reports.

Biomarkers in the management and treatment of men with metastatic castration-resistant prostate cancer.

H. Scher, A. Armstrong, D. Petrylak, 2012, European urology.

Prostate specific antigen best practice statement: 2009 update.

Peter H Gann, Peter C Albertsen, Misop Han, 2009, The Journal of urology.

Phase II trial of bicalutamide in patients with advanced prostate cancer in whom conventional hormonal therapy failed: a Southwest Oncology Group study (SWOG 9235).

C. Moinpour, E. Crawford, O. Kucuk, 2001, Urology.

Prostate cancer: epidemiology and health-related quality of life.

P. Scardino, D. Penson, M. Rossignol, 2008, Urology.

The Prostate

W. Isaacs, E. Antonarakis, C. Pritchard, 2019 .

Cabazitaxel vs docetaxel in chemotherapy-naive (CN) patients with metastatic castration-resistant prostate cancer (mCRPC): A three-arm phase III study (FIRSTANA).

F. Saad, J. Jassem, P. Mainwaring, 2016 .

Progression of metastatic castrate-resistant prostate cancer: impact of therapeutic intervention in the post-docetaxel space

A. Sartor, A. Sartor, A. O. Sartor, 2011, Journal of hematology & oncology.

Overall survival benefit and safety profile of radium-223 chloride, a first-in-class alpha-pharmaceutical: Results from a phase III randomized trial (ALSYMPCA) in patients with castration-resistant prostate cancer (CRPC) with bone metastases.

N. James, A. Cross, Chris Parker, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.